PF-07321332 Supply Agreement for Pandemic Purposes
Vaccines have been shown to be highly effective in the fight against COVID-19, to date. However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective. There is therefore an urgent need to find an effective alternative. So far there are no primary care antiviral drugs that can be easily dispensed specifically to treat SARS-CoV-2 and prevent its transmission in the community.This agreement is for the procurement of 250,000 units of PF-07321332/ritonavir . It is one of the...
Buyer
Department of Health and Social Care
Value
Not provided
Published
17 Nov 2021
Closes
17 Nov 2021
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 PF-07321332 Supply Agreement for Pandemic Purposes
Value not provided
Procurement of PF-07321332/ritonavir.
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.